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Motivating and enabling African Americans to make
physician visits is key to reducing race differences in mor-
tality. Race differences in patterns of physician utilization
are responsible for more than half of the race disparity 
in mortality outcomes. Costs of care are associated with
poorer survival rates. Higher priced care does not yield
better outcomes. Rather, costly care is associated with
higher rates of death and is likely an indicator of problem
severity.
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OBJECTIVES: Based on the empirical data of Taiwan’s
National Health Insurance (NHI) program, this study
intends to analyze the equity of access to health care
service for different disease and to test the following
hypotheses: a) Equity in health care utilization for minor
diseases; b) Equity in health care ﬁnance for catastrophe
diseases. METHODS: Since 1995, a compulsory social
health insurance scheme is implemented and has covered
about 97% of the total Taiwan population. Using the
household registration data (year 2000) from the Min-
istry of the Interior, the vital registration data (year 2000)
from the Department of Health and the insurance claim
data (years 1999 and 2000) from the Bureau of NHI, we
have analyzed the top utilization rate disease—upper res-
piratory infection, the top female mortality rate disease-
lung cancer and top female neoplasm incidence rate
cervix uteri cancer. To test the hypothesis, we classify 
the distribution of health care resource into 25 areas 
and analyze ﬁnancial impact of lung cancer and cervical
cancer in last year of life. RESULTS: There are 71% ben-
eﬁciaries who had at least once visited physician for URI,
which accounts for 31% of all cases number of outpa-
tients. There are 94% URI utilization rate for the 0–14
year-old beneﬁciaries. The empirical evidences conﬁrm
the ﬁrst hypothesis. For those women who died of lung
cancer and cervical cancer had not showed any health
care utilization and expenditure in their last year of life,
about 10%, 11% respectively. We had observed signiﬁ-
cant proportion of these cases either lived in rural areas
or under average national income. CONCLUSION: The
empirical evidences showed there are still ﬁnancial barrier
for catastrophe disease in resource scarce area.
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OBJECTIVES: Cumulative literature has overwhelmingly
suggested that income is positively associated with health.
This study aims to identify the domains of health with
which income is positively as well as negatively associ-
ated, using an elderly sample in a typical transitional
economy, Hong Kong. METHODS: Stratiﬁed dispropor-
tional random sampling in 1991–92 assembled a cohort
of 2032 elderly subjects who were aged 70 and above.
We measured the association between income and dif-
ferent domains of health and resource utilization using
bivariate and multivariate regression analyses. RESULTS:
After adjusting for age, sex, marital and employment
status, higher income was associated with better general
health (p = 0.03), better cognitive function (p < 0.0001),
lower geriatric depression scale (p < 0.0001), better
quality of sleep (p = 0.01) and fewer visits to general prac-
titioners (p = 0.01). Higher income was also associated
with higher Body Mass Index (p = 0.07), presence of cere-
brovascular disease (p = 0.04), fractures (p = 0.03) and
more deﬁciencies in Activities of Daily Living (p < 0.01).
CONCLUSIONS: Income was positively as well as neg-
atively associated with health in Hong Kong. Other tran-
sitional economies in the region may experience the same
pattern during rapid economic growth.
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OBJECTIVES: To observe the incidence of problems
associated with use of medical alarms in intensive care
units. METHODS: Adverse medical device events
(AMDE) and potential patient harm (hazards) associated
with alarms in two intensive care units (Shock-Trauma,
STICU, and Medical-Surgical, MSICU) within a tertiary
referral hospital were observed by a intensive care nurse
native to each unit and trained in observational tech-
niques by an anthropologist. The study was conducted
during consecutive 6-month periods between October
2001 and September 2002. Five rooms were continuously
directly monitored during each of approximately 104 six-
hour shifts (4 randomly selected shifts per week). Poisson-
method 95% conﬁdence intervals around incidence rates
were calculated. RESULTS: A total of 81 alarm events
were observed in the monitored rooms; 40 were AMDEs
and 41 hazards. Forty-ﬁve events were related to respira-
tion, oxygenation, or ventilation monitoring, 22 to blood
pressure, heart rate, or arrhythmia monitoring, 9 to an
infusion pump, and 1 to a feeding pump. Incidence rates
per 100 occupied observed bed-days for hazards and
AMDE (with 95% conﬁdence intervals) in the STICU
were, respectively, 20 (12–31) and 35 (24–49). The 
corresponding incidence rates for the MSICU were 20
220 Abstracts
(13–31) and 6 (2–12). A human factors analysis of the
circumstances of each case attributed 79% to a combi-
nation of user error and device malfunction or ﬂawed
alarm design. None of the events were documented in the
medical record or in incident reports. CONCLUSIONS:
Rates of alarm related problems in two ICUs were much
higher than reported in a routine reporting system and
indicate an understudied important threat to patient
safety. An assessment of risk factors for these events is in
progress.
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OBJECTIVES: To describe the pattern of use of alterna-
tive therapy, healthcare spending, and health-related
quality of life in Chinese osteoarthritis (OA) patients in
Hong Kong. METHODS: We conducted a retrospective,
cross-sectional study of 547 adult Chinese patients in
Hong Kong who have been diagnosed as having OA. We
deﬁned the alternative therapy as 1 of the 11 therapies
outlined in international publications. OA patients who
used alternative therapies and those who did not were
compared for their socio-economic status, disease proﬁle,
personal healthcare spending, and quality of life. Quality
of life was measured using a Health Utility Index based
upon SF-36 health surveys. We further investigated the
association between the use of alternative therapies and
personal healthcare spending, and its association with the
Health Utility Index, in multivariate regressions control-
ling for socio-economic variables, years of OA, and the
severity of OA. RESULTS: Of the 547 OA patients, 219
(38.2%) had used 1 or more of the 11 alternative thera-
pies for OA. The most commonly used therapies, (and the
percentage of patients who used them), were acupuncture
(21.4%), exercise (12%), herbal remedy (5.9%), lifestyle
diets (5.8%), energy healing (4.4%), and chiropractic
manipulation (3.8%). On average, payment for alterna-
tive therapies constitutes 5% of the overall personal
healthcare spending, and 29% of the out-of-pocket pay-
ments. CONCLUSION: The use of alternative therapies
was statistically signiﬁcantly associated with higher per-
sonal healthcare spending, after adjusting for socioeco-
nomic variables, years of OA and severity of OA. The use
of alternative therapies was not signiﬁcantly associated
with an improvement in quality of life in the regression
analysis.
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OBJECTIVES: Prior authorization (PA) is a poorly
studied, but commonly employed policy used by health
care payers to manage the rising costs of pharmacy 
beneﬁts. Our objective was to evaluate the impact of PA
policies for cyclooxygenase-2 (COX-2) inhibitors on 
prescription drug and medical service utilization in a
managed care Medicaid population. METHODS: The
analysis was conducted from January 1, 1999 to October
31, 2001 when PA policies were enacted for celecoxib and
rofecoxib. Monthly annualized rates of utilization were
estimated using medical and prescription drug billing
records. An autocorrelation-corrected segmented linear
regression model was developed to evaluate trends in 
utilization temporally associated with PA initiation. 
The primary analysis evaluated utilization of related 
drug classes (e.g. conventional NSAIDs, PPIs), and ofﬁce,
emergency, and hospital encounters in all enrolled
members. A secondary analysis was performed in a
cohort of prior NSAID (conventional and COX-2) users.
RESULTS: After each PA was activated, utilization 
of celecoxib and rofecoxib were immediately reduced
from 1.07 to 0.53 days supply/person-year (58.9% re-
duction; 95% CI: 50.0%–67.9%) and 0.96 to 0.52 
days supply/person-year (49.8% reduction; 95% CI:
40.5%–59.1%), respectively. Growth in utilization was
slowed for both agents (p < 0.0001). Utilization changes
were not observed in other drug classes. Similar trends
were observed in the secondary analysis. No changes 
in medical service use were noted with the exception of
emergency room visits, which increased by 18.0% (95%
CI: 2.2%–33.9%) and exhibited a higher growth rate
after the PA for celecoxib was enacted. A similar, non-
signiﬁcant trend was observed in the secondary analysis.
CONCLUSIONS: Utilization of rofecoxib and celecoxib
was reduced substantially following the implementation
of a PA policy. No important concomitant changes in the
use of other drug classes were detected. The small increase
in ER visits observed after the celecoxib PA was activated
is a concerning ﬁnding that warrants further study.
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OBJECTIVES: To analyze the market impact of the in-
troduction of the COX-2 inhibitors, Celebrex and Vioxx,
